Share buybacks are an alternative to dividends for returning value to shareholders. They can be a hugely valuable tool.

Pacira Biosciences has authorized a share buyback program of up to $300 million. The developer of non-opioid pain relievers said Thursday the repurchase program replaces a previous $150 million ...

The trend continues as GM just announced recently it approved a $0.03 per share increase to the dividend, or a 25% hike, and ...

As publicly listed firms are optimistic about the development prospects of the capital market, an increasing number of listed companies and executives are joining the ranks of share buybacks and ...

The program allows for the repurchase of up to 10% of the company’s outstanding common stock, which equates to approximately 10.6 million shares. This move follows the company’s transition from a ...

OPKO currently expects to fund the repurchase program from existing cash and cash equivalents, and future cash flows. The Company had approximately 671.6 million shares outstanding as of February 24, ...

The company expects to use a combination of ~$350 million of cash on hand and up to $150 million in short-term debt to finance the accelerated share repurchases. PVH (NYSE: PVH) expects to repay the ...

The earnings growth will be supported by an accelerated $500 million stock buyback initiative, which will have the effect of reducing the company's total shares outstanding and distributing ...